In contrast, loss of function of RUNX1 causes lenalidomide resistance in del(5q) MDS cells, suggesting that RUNX1 function is required for lenalidomide sensitivity [75, 76]. The gene discussed is RUNX1; the disease is myelodysplastic syndrome.